Literature DB >> 21947782

Overexpression of receptor for hyaluronan-mediated motility (RHAMM) in MC3T3-E1 cells induces proliferation and differentiation through phosphorylation of ERK1/2.

Hiroko Hatano1, Hideo Shigeishi, Yasusei Kudo, Koichiro Higashikawa, Kei Tobiume, Takashi Takata, Nobuyuki Kamata.   

Abstract

Receptor for hyaluronan (HA)-mediated motility (RHAMM) was first described as a soluble HA binding protein released by sub-confluent migrating cells. We previously found that RHAMM was highly expressed and plays an important role in proliferation in the human cementifying fibroma (HCF) cell line, which we previously established. HCF is a benign fibro-osseous neoplasm of the jaw and is composed of fibrous tissue containing varying amounts of mineralized material. However, the pathogenesis of HCF is not clear. In this paper, we examined the roles of RHAMM in osteoblastic cells. We generated RHAMM-overexpressing MC3T3-E1 cells and examined the cell proliferation and differentiation of osteoblastic cells. In MC3T3-E1 cells, overexpressing RHAMM was located intracellular and activated ERK1/2. Interestingly, the ERK1/2 activated by RHAMM overexpression promoted cell proliferation and suppressed the differentiation of osteoblastic cells. Our findings strongly suggest that RHAMM may play a key role in the osteoblastic differentiation process. The rupture of balance from differentiation to proliferation induced by RHAMM overexpression may link to the pathogenesis of bone neoplasms such as HCF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21947782     DOI: 10.1007/s00774-011-0318-0

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  30 in total

Review 1.  Signaling properties of hyaluronan receptors.

Authors:  Eva A Turley; Paul W Noble; Lilly Y W Bourguignon
Journal:  J Biol Chem       Date:  2001-11-20       Impact factor: 5.157

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  Ras-MAPK signaling in osteogenic differentiation: friend or foe?

Authors:  Aaron Schindeler; David G Little
Journal:  J Bone Miner Res       Date:  2006-09       Impact factor: 6.741

4.  Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation.

Authors:  C L Hall; B Yang; X Yang; S Zhang; M Turley; S Samuel; L A Lange; C Wang; G D Curpen; R C Savani; A H Greenberg; E A Turley
Journal:  Cell       Date:  1995-07-14       Impact factor: 41.582

5.  RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44-EGFR.

Authors:  Hiroko Hatano; Hideo Shigeishi; Yasusei Kudo; Koichiro Higashikawa; Kei Tobiume; Takashi Takata; Nobuyuki Kamata
Journal:  Lab Invest       Date:  2010-10-18       Impact factor: 5.662

6.  Overexpression of the receptor for hyaluronan-mediated motility (RHAMM) characterizes the malignant clone in multiple myeloma: identification of three distinct RHAMM variants.

Authors:  M Crainie; A R Belch; M J Mant; L M Pilarski
Journal:  Blood       Date:  1999-03-01       Impact factor: 22.113

7.  Characterization of the murine gene encoding the hyaluronan receptor RHAMM.

Authors:  J Entwistle; S Zhang; B Yang; C Wong; Q Li; C L Hall; J A; M Mowat; A H Greenberg; E A Turley
Journal:  Gene       Date:  1995-10-03       Impact factor: 3.688

Review 8.  Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.

Authors:  P J Roberts; C J Der
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

9.  Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer.

Authors:  I Zlobec; L Terracciano; L Tornillo; U Günthert; T Vuong; J R Jass; A Lugli
Journal:  Gut       Date:  2008-04-24       Impact factor: 23.059

10.  Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44.

Authors:  A Masellis-Smith; A R Belch; M J Mant; E A Turley; L M Pilarski
Journal:  Blood       Date:  1996-03-01       Impact factor: 22.113

View more
  8 in total

1.  RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia.

Authors:  Sylvia Snauwaert; Stijn Vanhee; Glenn Goetgeluk; Greet Verstichel; Yasmine Van Caeneghem; Imke Velghe; Jan Philippé; Zwi N Berneman; Jean Plum; Tom Taghon; Georges Leclercq; Kris Thielemans; Tessa Kerre; Bart Vandekerckhove
Journal:  Haematologica       Date:  2012-04-24       Impact factor: 9.941

2.  Hyaluronic acid, CD44 and RHAMM regulate myoblast behavior during embryogenesis.

Authors:  Yue Leng; Ammara Abdullah; Michael K Wendt; Sarah Calve
Journal:  Matrix Biol       Date:  2018-08-18       Impact factor: 11.583

3.  A case of cervical cancer expressed three mRNA variant of Hyaluronan-mediated motility receptor.

Authors:  Vanessa Villegas-Ruíz; Mauricio Salcedo; Alejandro Zentella-Dehesa; Edén V Montes de Oca; Edgar Román-Basaure; Alejandra Mantilla-Morales; Víctor M Dávila-Borja; Sergio Juárez-Méndez
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

4.  Hyaluronic acid regulates a key redox control factor Nrf2 via phosphorylation of Akt in bovine articular chondrocytes.

Authors:  Yuta Onodera; Takeshi Teramura; Toshiyuki Takehara; Kanji Fukuda
Journal:  FEBS Open Bio       Date:  2015-05-29       Impact factor: 2.693

5.  HMMR antisense RNA 1, a novel long noncoding RNA, regulates the progression of basal-like breast cancer cells.

Authors:  Wei Liu; Jun Ma; Yong Cheng; Hongbo Zhang; Wengguang Luo; Hongyan Zhang
Journal:  Breast Cancer (Dove Med Press)       Date:  2016-11-24

6.  Integrative analysis of histomorphology, transcriptome and whole genome resequencing identified DIO2 gene as a crucial gene for the protuberant knob located on forehead in geese.

Authors:  Yan Deng; Shenqiang Hu; Chenglong Luo; Qingyuan Ouyang; Li Li; Jiaming Ma; Zhenping Lin; Junpeng Chen; Hehe Liu; Jiwei Hu; Guohong Chen; Dingming Shu; Yuxuan Pan; Bo Hu; Hua He; Hao Qu; Jiwen Wang
Journal:  BMC Genomics       Date:  2021-06-30       Impact factor: 3.969

Review 7.  The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression.

Authors:  Dragana Nikitovic; Katerina Kouvidi; Nikos K Karamanos; George N Tzanakakis
Journal:  Biomed Res Int       Date:  2013-09-05       Impact factor: 3.411

8.  The hyaluronan-mediated motility receptor RHAMM promotes growth, invasiveness and dissemination of colorectal cancer.

Authors:  Valentina Mele; Lena Sokol; Viktor Hendrik Kölzer; Dennis Pfaff; Manuele Giuseppe Muraro; Irene Keller; Zahnd Stefan; Irene Centeno; Luigi Maria Terracciano; Heather Dawson; Inti Zlobec; Giandomenica Iezzi; Alessandro Lugli
Journal:  Oncotarget       Date:  2017-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.